1. General
  2. Others

  3. Others

Dr. Reddy launches Sildenafil tablets

India Infoline News Service | Mumbai | November 19, 2012 09:51 IST

The REVATIO brand had U.S. sales of approximately $338.67 Million for the most recent twelve months ending September 2012 according to IMS Health.

Dr. Reddy's Laboratories announced today that it has launched Sildenafil Tablets (20 mg), a bioequivalent generic version of REVATIO (Sildenafil) Tablets in the US market on November16, 2012, following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy's ANDA for Sildenafil Tablets.


The REVATIO brand had U.S. sales of approximately $338.67 Million for the most recent twelve months ending September 2012 according to IMS Health.


Dr. Reddy's Sildenafil Tablets in 20 mg are available in 90 count bottle sizes.

BSE 3,161.70 63.60(2.05%)
NSE 3,168.30 73.40(2.37%)
As on: 01 Jan 70, 05:30

***Note: This is a BSE Chart









 

 
 
 
Recent Reports
News